Clinical Trials Browser

Phase 2 × INDUSTRY × Dalteparin × Clear all

NCT00952380 2019-04-16

Fragmin for the Treatment of Acute VTE in Pediatric Cancer Patients

Phase 2 Completed

38 enrolled 30 charts

Classical hematology

Venous Thromboembolism